Logo image of SEEL

SEELOS THERAPEUTICS INC (SEEL) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:SEEL - US81577F3073 - Common Stock

1.28 USD
-1.17 (-47.76%)
Last: 10/15/2024, 8:00:02 PM
1.45 USD
+0.17 (+13.28%)
After Hours: 10/15/2024, 8:00:02 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to SEEL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 122.4. This target is 9462.5% above the current price.
SEEL was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SEEL.
In the previous month the buy percentage consensus was at a similar level.
SEEL was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

SEEL Historical Analyst RatingsSEEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -83 -75 -67 -59 -51 -43 -35 -27 -19 -11 -3 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.28121.20122.40122.40126.00 - 9,368.75% 9,462.50% 9,462.50% 9,743.75%

Related screens

SEEL Current Analyst RatingSEEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-09-22 Guggenheim Downgrade Buy -> Neutral
2023-09-21 Cantor Fitzgerald Downgrade Overweight -> Neutral
2023-09-21 Guggenheim Downgrade Buy -> Neutral
2023-09-21 Benchmark Maintains Speculative Buy -> Speculative Buy
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-15 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-06-23 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-06-23 Benchmark Reiterate Speculative Buy -> Speculative Buy
2023-05-16 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-05-15 BTIG Maintains Buy -> Buy
2023-03-24 Benchmark Maintains Buy
2021-09-27 Roth Capital Upgrade Neutral -> Buy
2021-08-10 Roth Capital Maintains Neutral
2021-07-01 Guggenheim Initiate Buy
2021-06-01 Cantor Fitzgerald Initiate Overweight
2021-03-30 B. Riley FBR Initiate Buy
2021-03-12 BTIG Initiate Buy

SEELOS THERAPEUTICS INC / SEEL FAQ

What is the average price target for SEELOS THERAPEUTICS INC (SEEL) stock?

7 analysts have analysed SEEL and the average price target is 122.4 USD. This implies a price increase of 9462.5% is expected in the next year compared to the current price of 1.28.


What is the consensus rating for SEEL stock?

The consensus rating for SEELOS THERAPEUTICS INC (SEEL) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.